2023-05-10 06:26:12 ET
- LifeStance Health Group press release ( NASDAQ: LFST ): Q1 GAAP EPS of -$0.09 beats by $0.02 .
- Revenue of $252.6M (+24.4% Y/Y) beats by $5.91M .
- Adjusted EBITDA of $10.1 million compared to Adjusted EBITDA of $12.5 million
- LifeStance used $7.9 million cash flow from operations during the first quarter of 2023. The Company ended the first quarter with cash of $68.3 million and net long-term debt of $224.8 million.
- LifeStance is raising full year revenue and Center Margin guidance, with the following outlook for 2023
- The Company expects full year revenue of $990 million to $1.02 billion, vs $996.21M Consensus
- Center Margin of $274 to $290 million, and Adjusted EBITDA of $50 to $62 million.
- For the second quarter of 2023, the Company expects total revenue of $250 to $260 million, vs $250.04M Consensus
- Center Margin of $69 to $76 million, and Adjusted EBITDA of $10 to $16 million.
For further details see:
LifeStance Health Group GAAP EPS of -$0.09 beats by $0.02, revenue of $252.6M beats by $5.91M